![Diana Moore](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Diana Moore
Public Communications Contact chez AMICUS THERAPEUTICS, INC.
Profil
Diana Moore is currently the Head-Global Communications at Amicus Therapeutics, Inc. and is also a Member at the National Investor Relations Institute.
She previously worked as the Director-Investor Relations & Business Development at Advaxis, Inc. Ms. Moore has a graduate degree from The University of Manchester and an undergraduate degree from Princeton University.
Postes actifs de Diana Moore
Sociétés | Poste | Début |
---|---|---|
AMICUS THERAPEUTICS, INC. | Public Communications Contact | 01/10/2015 |
National Investor Relations Institute
![]() National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Corporate Officer/Principal | - |
Anciens postes connus de Diana Moore
Sociétés | Poste | Fin |
---|---|---|
AYALA PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Formation de Diana Moore
Princeton University | Undergraduate Degree |
The University of Manchester | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
AMICUS THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Advaxis, Inc.
![]() Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
National Investor Relations Institute
![]() National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Commercial Services |